Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05615662

Meru Health Program to Treat Depression in Primary Care

Conditions: Depression, Anxiety

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 330
Sponsor: Meru Health, Inc.

Location: United States

Summary

Meru Health Inc. seeks to further validate the Meru Health Program (MHP) as a single solution to screening, referral, and treatment in primary care as compared to treatment as usual using a Randomized Controlled Trial (RCT) study design. The goal of this study is to determine the feasibility, effectiveness, and implementability of this digital mental health (DMH) solution.If proven effective and implementable, more widely integrating the MHP into primary care has the potential to improve the systems of screening, referral, and treatment for depression nationwide. This, in turn, will serve as a solution to improve access to effective care for the millions of Americans currently suffering from depression, ultimately reducing its public health burden.

Eligibility Criteria

Inclusion Criteria:PHQ-9 score of 10 or more at the time of screeningWilling to commit to the Meru Health Program if selectedProficient in the English languageAt least 18 years of age at the time of enrollmentHas a valid mailing addressOwns an Apple or Android smartphone with 1 of the 3 most recent versions of the operating system software.Exclusion Criteria:Active suicide intent with plan to actSubstance use disorder in the past 3 monthsEver been diagnosed with bipolar disorderEver been diagnosed with a psychotic disorderCurrently pregnantLess than 3 months postpartum

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05615662). StuddyBuddy aggregates publicly available trial information.